Scinus Cell Expansion BV, a RegMed XB partner, has made the next step in bringing solutions to patients. Prometheus at KU Leuven, Belgium, installed a novel bioreactor from Scinus Cell Expansion B.V.
Joint defects involving the surface cartilage and underlying bone are one of the major causes of osteoarthritis. Breakthroughs in developmental biology, have allowed Prometheus, the Division of Skeletal Tissue Engineering at KU Leuven, Belgium to create cartilaginous micro-tissues that can be used as building blocks for the bottom-up, 3D-assembly of functional tissue implants. As a result of a productive collaboration with Scinus Cell Expansion B.V. Cell Expansion Netherlands B.V., Prometheus has successfully adapted its existing manual, research-scale cell expansion process for use with the SCINUS bio-reactor. The work was conducted as part of an ongoing collaboration between Flanders and the Netherlands - RegMed XB (Regenerative Medicine Crossing Borders) and is funded in Flanders by EWI (Dept. of Economy, Science and Entrepreneurship).